---
figid: PMC6680212__IJU-23-654-g005
figlink: /pmc/articles/PMC6680212/figure/iju13137-fig-0005/
number: Figure 5
caption: 'Conceivable mechanisms of resistance to abiraterone and enzalutamide. There
  are several molecular mechanisms proposed to explain resistance to abiraterone and
  enzalutamide: increased intratumoral androgen biosynthesis as a result of upregulation
  of CYP17 enzymes or a gain‐of‐function mutation (N367T) in 3βHSD1; AR gain‐of‐function
  mutations that allow the AR to be activated by anti‐androgens; alternative steroid
  receptors, such as GR or PR activation, to bypass AR; reciprocal feedback regulation
  of PI3K/Akt/mTOR pathway; neuroendocrine transdifferentiation; and constitutively
  active AR‐Vs with truncated LBD. Some novel AR‐targeted agents that are in clinical
  development with potential to overcome resistance are shown.'
pmcid: PMC6680212
papertitle: 'Androgen receptor targeted therapies in castration‐resistant prostate
  cancer: Bench to clinic.'
reftext: Yusuke Imamura, et al. Int J Urol. 2016 Aug;23(8):654-665.
pmc_ranked_result_index: '152604'
pathway_score: 0.9624292
filename: IJU-23-654-g005.jpg
figtitle: Conceivable mechanisms of resistance to abiraterone and enzalutamide
year: '2016'
organisms: Homo sapiens
ndex: d34c3e1a-ded9-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6680212__IJU-23-654-g005.html
  '@type': Dataset
  description: 'Conceivable mechanisms of resistance to abiraterone and enzalutamide.
    There are several molecular mechanisms proposed to explain resistance to abiraterone
    and enzalutamide: increased intratumoral androgen biosynthesis as a result of
    upregulation of CYP17 enzymes or a gain‐of‐function mutation (N367T) in 3βHSD1;
    AR gain‐of‐function mutations that allow the AR to be activated by anti‐androgens;
    alternative steroid receptors, such as GR or PR activation, to bypass AR; reciprocal
    feedback regulation of PI3K/Akt/mTOR pathway; neuroendocrine transdifferentiation;
    and constitutively active AR‐Vs with truncated LBD. Some novel AR‐targeted agents
    that are in clinical development with potential to overcome resistance are shown.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - PIK3CB
  - PIK3CA
  - ATP2A2
  - AR
  - ADI1
  - CYP17A1
  - PIK3R6
  - PIK3CG
  - AKT3
  - MTOR
  - PIK3R5
  - PIK3CD
  - PIK3R3
  - AKT1
  - AKT2
  - PIK3R4
  - androgen
  - androstenedione
  - DHEA
  - Niclosamide
  - Progesterone
  - Testosterone
genes:
- word: PI3K/Akt/MTOR
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: PI3K/Akt/MTOR
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: DAR
  symbol: DAR
  source: hgnc_prev_symbol
  hgnc_symbol: ATP2A2
  entrez: '488'
- word: AR
  symbol: AR
  source: hgnc_symbol
  hgnc_symbol: AR
  entrez: '367'
- word: ARD
  symbol: ARD
  source: hgnc_alias_symbol
  hgnc_symbol: ADI1
  entrez: '55256'
- word: CYP17
  symbol: CYP17
  source: hgnc_prev_symbol
  hgnc_symbol: CYP17A1
  entrez: '1586'
- word: PI3K/Akt/MTOR
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: PI3K/Akt/MTOR
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: PI3K/Akt/MTOR
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: PI3K/Akt/MTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: PI3K/Akt/MTOR
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: PI3K/Akt/MTOR
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: PI3K/Akt/MTOR
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: PI3K/Akt/MTOR
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: PI3K/Akt/MTOR
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: PI3K/Akt/MTOR
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
chemicals:
- word: androgen
  source: MESH
  identifier: D000728
- word: androstenedione
  source: MESH
  identifier: D000735
- word: DHEA
  source: MESH
  identifier: D003687
- word: Niclosamide
  source: MESH
  identifier: D009534
- word: Progesterone
  source: MESH
  identifier: D011374
- word: Testosterone
  source: MESH
  identifier: D013739
diseases: []
---
